By ordering, I confirm that I am ordering the NIPTIFY Focus Plus test at the patient's request. The test evaluates the risks of fetal trisomy of 13, 18, and 21 chromosomes, DiGeorge (22q11) microdeletion syndrome, monosomy X (45,X), and determines fetal chromosomal sex. I confirm that the patient has been informed about the possible results, risks, and limitations of the NIPTIFY Focus Plus test and has signed the consent form. I confirm that here presented data is correct.